Outpatient management of heart failure in the United States, 2006-2008

Texas Heart Institute Journal

Volumn 41, Issue 3, 2014, Pages 253-261

  Mosalpuria, Kailash ^a   Agarwal, Sunil K ^b,d   Yaemsiri, Sirin ^c,e   Pierre Louis, Bredy ^a   Saba, Samir ^d   Alvarez, Rene ^d,f   Russell, Stuart D ^b  

^a HARLEM HOSPITAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c The University of North Carolina at Chapel Hill   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e National Center of Health   (United States)

^f TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Ambulatory care standards; Cardiovascular agents therapeutic use; Clinical trials as topic; Comprehensive health care; Drug utilization statistics Numerical data; Health care surveys; Heart failure drug therapy economics epidemiology prevention control; Office visits statistics numerical data trends utilization; Outcome assessment (health care) trends; Quality assurance, health care

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CARDIOVASCULAR AGENT;

AGED; ARTICLE; CARDIOLOGIST; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DRUG USE; EXERCISE; FEMALE; HEALTH CARE SYSTEM; HEALTH EDUCATION; HEART FAILURE; HOSPITALIZATION; HUMAN; LIFESTYLE MODIFICATION; MALE; OUTPATIENT CARE; QUESTIONNAIRE; SMOKING CESSATION; STRESS MANAGEMENT; UNITED STATES; AMBULATORY CARE; ATTITUDE TO HEALTH; CLINICAL PRACTICE; HEALTH CARE SURVEY; MULTIVARIATE ANALYSIS; PATIENT EDUCATION; PRACTICE GUIDELINE; RISK; RISK FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TIME; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; AMBULATORY CARE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR AGENTS; COMORBIDITY; DRUG UTILIZATION REVIEW; FEMALE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; OFFICE VISITS; PATIENT EDUCATION AS TOPIC; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84901775830     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: 10.14503/THIJ-12-2947     Document Type: Article

References (42)

1. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997;133 (6):703-12.
2. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association [published errata appear in Circulation 2011;123(6):e240 and Circulation 2011;124(16):e246]. Circulation 2011;123(4):e18-e209.
3. Kosiborod M, Lichtman JH, Heidenreich PA, Normand SL, Wang Y, Brass LM, Krumholz HM. National trends in outcomes among elderly patients with heart failure. Am J Med 2006;119(7):616.e1-616.e7.
4. Rathore SS, Masoudi FA, Wang Y, Curtis JP, Foody JM, Havranek EP, Krumholz HM. Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J 2006;152(2):371-8.
5. Oddone EZ, Weinberger M, Horner M, Mengel C, Goldstein F, Ginier P, et al. Classifying general medicine readmissions. Are they preventable? Veterans Affairs Cooperative Studies in Health Services Group on Primary Care and Hospital Readmissions. J Gen Intern Med 1996;11(10):597-607.
6. Bonow RO, Bennett S, Casey DE Jr, Ganiats TG, Hlatky MA, Konstam MA, et al. ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society of America. Circulation 2005;112(12):1853-87.
7. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the International Society for Heart and Lung Transplantation [published erratum appears in J Am Coll Cardiol 2009;54(25):2464. J Am Coll Cardiol 2009;53 (15):e1-e90.
8. Cherry DK, Hing E, Woodwell DA, Rechtsteiner EA. National Ambulatory Medical Care Survey: 2006 summary. Natl Health Stat Report 2008;(3):1-39.
9. Cherry DK, Woodwell DA, Rechtsteiner EA. National Ambulatory Medical Care Survey: 2005 summary. Adv Data 2007;(387):1-39.
10. Middleton K, Hing E, Xu J. National Hospital Ambulatory Medical Care Survey: 2005 outpatient department summary. Adv Data 2007;(389):1-34.
11. Hugli O, Braun JE, Kim S, Pelletier AJ, Camargo CA Jr. United States emergency department visits for acute decompensated heart failure, 1992 to 2001. Am J Cardiol 2005;96 (11):1537-42.
12. U.S. Food and Drug Administration. National drug code directory. Silver Spring (MD): 1995.
13. Stafford RS, Saglam D, Causino N, Starfield B, Culpepper L, Marder WD, Blumenthal D. Trends in adult visits to primary care physicians in the United States. Arch Fam Med 1999;8 (1):26-32.
14. Stafford RS, Saglam D, Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med 1997;157(21):2460-4.
15. Chan PS, Oetgen WJ, Buchanan D, Mitchell K, Fiocchi FF, Tang F, et al. Cardiac performance measure compliance in outpatients: the American College of Cardiology and National Cardiovascular Data Registry's PINNACLE (Practice Innovation And Clinical Excellence) program. J Am Coll Cardiol 2010;56(1):8-14.
16. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, et al. Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail 2008;1(2):98-106.
17. Cohn JN. The management of chronic heart failure. N Engl J Med 1996;335(7):490-8.
18. Deedwania PC, Carbajal EV. Secondary prevention after myocardial infarction. Too many choices, which ones work? Arch Intern Med 1993;153(3):285-8.
19. Deedwania PC, Amsterdam EA, Vagelos RH. Evidencebased, cost-effective risk stratification and management after myocardial infarction. California Cardiology Working Group on Post-MI Management. Arch Intern Med 1997;157(3):273-80.
20. O'Connor CM, Carson PE, Miller AB, Pressler ML, Belkin RN, Neuberg GW, et al. Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective Randomized Amlodipine Survival Evaluation. Am J Cardiol 1998;82(7):881-7.
21. Cohn JN, Ziesche S, Smith R, Anand I, Dunkman WB, Loeb H, et al. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group. Circulation 1997;96(3):856-63.
22. Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med 1996;335(15):1107-14.
23. Edep ME, Shah NB, Tateo IM, Massie BM. Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines. J Am Coll Cardiol 1997;30(2):518-26.
24. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008;359(23): 2456-67.
25. Fu M, Zhou J, Sun A, Zhang S, Zhang C, Zou Y, et al. Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction--a meta analysis of 7 prospective clinical studies. Int J Cardiol 2012;155(1):33-8.
26. Piccini JP, Hernandez AF, Dai D, Thomas KL, Lewis WR, Yancy CW, et al. Use of cardiac resynchronization therapy in patients hospitalized with heart failure. Circulation 2008;118 (9):926-33.
27. Bart BA, Gattis WA, Diem SJ, O'Connor CM. Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction. Am J Cardiol 1997;79(8):1118-20.
28. Houghton AR, Cowley AJ. Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners? Int J Cardiol 1997;59(1):7-10.
29. Philbin EF, Andreaou C, Rocco TA, Lynch LJ, Baker SL. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol 1996;77(10):832-8.
30. Pearson TA, McBride PE, Miller NH, Smith SC. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 8. Organization of preventive cardiology service. J Am Coll Cardiol 1996;27(5):1039-47.
31. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353(9169):2001-7.
32. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353(9146):9-13.
33. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344(22):1651-8.
34. Sin DD, McAlister FA. The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure. Am J Med 2002;113(8): 650-6.
35. Stafford RS, Radley DC. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol 2003;41(1):56-61.
36. Stevenson LW. Projecting heart failure into bankruptcy in 2012? Am Heart J 2011;161(6):1007-11.
37. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333(18):1190-5.
38. Philbin EF. Comprehensive multidisciplinary programs for the management of patients with congestive heart failure. J Gen Intern Med 1999;14(2):130-5.
39. Rich MW, Nease RF. Cost-effectiveness analysis in clinical practice: the case of heart failure. Arch Intern Med 1999;159 (15):1690-700.
40. Gustafsson F, Arnold JM. Heart failure clinics and outpatient management: review of the evidence and call for quality assurance. Eur Heart J 2004;25(18):1596-604.
41. Lee DS, Donovan L, Austin PC, Gong Y, Liu PP, Rouleau JL, Tu JV. Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care 2005;43(2):182-8.
42. Goff DC Jr, Pandey DK, Chan FA, Ortiz C, Nichaman MZ. Congestive heart failure in the United States: is there more than meets the I(CD code)? The Corpus Christi Heart Project. Arch Intern Med 2000;160(2):197-202.